AIP (NASDAQ) Form 144: Trustee 10b5-1 sales and 90,839 shares listed for sale
Rhea-AI Filing Summary
AIP filing a Form 144 reporting proposed sales of Common Stock. The filing lists 70,000 shares from previously exercised stock options (dated 12/28/2020) and 20,839 shares issuable under Restricted Stock Units (dated 06/03/2026) as securities to be sold. The excerpt also details multiple 10b5-1 sales by the Atiq Raza & N Saraiya 2012 Rev Trust totaling sales on 03/02/2026, 03/04/2026, 04/17/2026, 04/20/2026, and 05/01/2026 with individual share amounts shown in the table.
Positive
- None.
Negative
- None.
Insights
Form 144 documents proposed insider/resale sales under a 10b5-1 plan and planned disposals of option/RSU-derived shares.
The filing lists the specific securities proposed for sale, including 70,000 shares from exercised options and 20,839 RSU shares, and records executed 10b5-1 transactions by a named trust on multiple dates. These entries are administrative notices required for brokered resale of restricted or control securities.
Timing and cash‑flow recipients are explicit for executed 10b5-1 sales (dates and proceeds per line items). Future filings or confirmations will show actual settlement details.
Recorded 10b5-1 sales provide transaction-level detail; proposed sales tie to option exercises and RSU vesting.
The table lists five executed 10b5-1 sales with share counts and aggregate dollar amounts; these appear to be dispositions by the Atiq Raza & N Saraiya 2012 Rev Trust. The securities to be sold section separately lists option-derived and RSU-derived shares with grant/exercise dates.
Cash‑flow treatment for proposed sales is the selling holder; settlement specifics and whether sales are subject to any cap or limitation are not stated in the excerpt.